ME News reported on July 21 (UTC+8) that Ostium, an RWA trading platform on Arbitrum, announced that its team is working to relaunch the platform this week, with auditors, third-party cybersecurity experts, and the engineering team conducting final checks. Ostium stated that upon trading resumption, open positions will be repriced based on real-time market prices at the time of recovery and will not be liquidated due to price fluctuations during the suspension; however, if a position falls below the liquidation threshold at resumption, it will be liquidated. All open orders will remain unchanged. Regarding affected liquidity providers, Ostium Labs said it is developing a recovery plan, which will involve compensation funded from its own balance sheet in collaboration with both new and existing partners; details will be announced later. (Source: ODAILY)
Ostium to Compensate Affected Liquidity Providers from Its Balance Sheet
KuCoinFlashShare
Ostium, an RWA trading platform on Arbitrum, announced on July 21 (UTC+8) that it is preparing to resume operations this week, with auditors and security experts conducting final checks. Positions will be marked to market upon resumption, but will not be liquidated due to price fluctuations during the pause. All orders remain unchanged. Ostium Labs is developing a recovery plan to compensate liquidity providers using its balance sheet and support from new partners; details will be shared later. Liquidity providers are advised to monitor altcoins for potential market shifts.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.